Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mining the Antibody Repertoire for Solutions to SARS-CoV-2

Cell Host & Microbe(2020)10.1016/j.chom.2020.09.010Source: DataRank Database

Mining the Antibody Repertoire for Solutions to SARS-CoV-2 is a research paper published in Cell Host & Microbe (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.05)OA: bronzeTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Aaron M. Rosenfeld ORCID,Eline T. Luning Prak ORCID,Wenzhao Meng ORCID

Live enrichment

PubMed:33031765 PMC:PMC7539899 OpenAlex:https://openalex.org/W3092394108

NCI NIH HHS

Grant: P30 CA016520

NIDDK NIH HHS

Grant: UC4 DK112217

NIAID NIH HHS

Grant: P01 AI106697

NIAID NIH HHS

Grant: UM1 AI144288

National Institutes of Health

Grant: 5UM1AI144288-02

University of Pennsylvania Clinical Autoimmunity Center of Excellence

National Institutes of Health

Grant: 1UC4DK112217-01

Penn integrated Human Pancreas procurement and Analysis Program

National Institutes of Health

Grant: 2P30CA016520-35

Abramson Cancer Center Support Grant

National Institutes of Health

Grant: 5P01AI106697-02

Bioinformatics

National Institutes of Health

FWCI

0.05

Citation Percentile

0.5%

Citation Trend

2021

2022

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1931312820305138/pdf

publisherhttp://www.cell.com/article/S1931312820305138/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312820305138?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312820305138?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2020.09.010

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0301 basic medicine03 medical and health sciencesAntibodies, ViralAntibody FormationB-LymphocytesBetacoronavirusCOVID-19Coronavirus InfectionsHumansImmunoglobulin GPandemicsPneumonia, ViralSARS-CoV-2Severe Acute Respiratory Syndrome

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2Antibodies, ViralAntibody FormationB-LymphocytesHumansImmunoglobulin GPneumonia, ViralCoronavirus InfectionsSevere Acute Respiratory SyndromePandemics

Keywords

BiologyPolyclonal antibodiesAntibodyRepertoireAntibody RepertoireVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Sequence (biology)Virus2019-20 coronavirus outbreakVaccinationImmunologyHost (biology)Antibody responseComputational biologyGeneticsInfectious disease (medical specialty)B-LymphocytesSARS-CoV-2Pneumonia, ViralCOVID-19PreviewAntibodies, ViralSevere Acute Respiratory SyndromeMicrobiologyBetacoronavirusImmunoglobulin GAntibody FormationHumansParasitologyCoronavirus InfectionsPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being